LNSR
LNSR
NASDAQ · Health Care

Lensar Inc

$5.71
-0.01 (-0.17%)
As of Jun 30, 10:30 PM ET ·
Financial Highlights (FY 2026)
Revenue
62.41M
Net Income
-36,610,103
Gross Margin
46.4%
Profit Margin
-58.7%
Rev Growth
+18.2%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 46.4% 46.4% 57.4% 57.4%
Operating Margin -42.1% -37.9% 10.3% 10.3%
Profit Margin -58.7% -55.7% 9.6% 8.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 62.41M 52.78M 55.38M 51.89M
Gross Profit 28.96M 24.50M 31.77M 29.77M
Operating Income -26,248,449 -19,981,057 5.73M 5.35M
Net Income -36,610,103 -27,868,639 5.32M 4.60M
Gross Margin 46.4% 46.4% 57.4% 57.4%
Operating Margin -42.1% -37.9% 10.3% 10.3%
Profit Margin -58.7% -55.7% 9.6% 8.9%
Rev Growth +18.2% +18.2% +8.2% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 15.51M 16.29M
Total Equity 70.64M 78.05M
D/E Ratio 0.22 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -25,264,508 -20,300,501 9.24M 7.86M
Free Cash Flow 5.04M 4.51M